This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terekhova, D.
Right arrow Articles by Cabello, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terekhova, D.
Right arrow Articles by Cabello, F. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2002, p. 3637-3640, Vol. 46, No. 11
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.11.3637-3640.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Erythromycin Resistance in Borrelia burgdorferi

Darya Terekhova,1 Marina L. Sartakova,1 Gary P. Wormser,2 Ira Schwartz,1 and Felipe C. Cabello1*

Departments of Microbiology and Immunology,1 Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, New York 105952

Received 3 January 2002/ Returned for modification 1 May 2002/ Accepted 25 July 2002

Susceptibility testing of laboratory strains and clinical isolates of Borrelia burgdorferi indicates that resistance to erythromycin is present in them. Evaluation of the MICs, minimal bactericidal concentrations, and kinetics of bacterial killing of erythromycin suggests that this resistance is increased by preexposure to the antibiotic, is dependent on inoculum size, and may be the result of selection of subpopulations of bacterial cells with increased resistance.

* Corresponding author. Mailing address: Departments of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595. Phone: (914) 594-4182. Fax: (914) 594-4176. E-mail: cabello{at}nymc.edu.

Antimicrobial Agents and Chemotherapy, November 2002, p. 3637-3640, Vol. 46, No. 11
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.11.3637-3640.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Hodzic, E., Feng, S., Holden, K., Freet, K. J., Barthold, S. W. (2008). Persistence of Borrelia burgdorferi following Antibiotic Treatment in Mice. Antimicrob. Agents Chemother. 52: 1728-1736 [Abstract] [Full Text]  
  • Criswell, D., Tobiason, V. L., Lodmell, J. S., Samuels, D. S. (2006). Mutations Conferring Aminoglycoside and Spectinomycin Resistance in Borrelia burgdorferi. Antimicrob. Agents Chemother. 50: 445-452 [Abstract] [Full Text]  
  • Hunfeld, K.-P., Wichelhaus, T. A., Rodel, R., Acker, G., Brade, V., Kraiczy, P. (2004). Comparison of In Vitro Activities of Ketolides, Macrolides, and an Azalide against the Spirochete Borrelia burgdorferi. Antimicrob. Agents Chemother. 48: 344-347 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»